Media

Vicore Pharma to Present at the Jefferies Global Healthcare Conference

HealthCap invests in Neobiomics to support continued growth in neonatal care

Intervacc completes successful evaluation of US strain of strangles pathogen ahead of clinical trials

Hemab Therapeutics Reports First Quarter 2026 Financial Results

Oncopepetides – Bulletin from the Annual General Meeting

Adcendo ApS Provides Updates on Pipeline Progress and Recent Achievements for Its First- and Best-in-Class Antibody-Drug Conjugates

Oncopeptides – Study confirms use of Pepaxti in a broader population, with strong data in the 50% of RRMM patients that suffer from reduced kidney function

Oncopeptides receives formal approval from Norwegian authorities to initiate Window-of-Opportunity study in glioblastoma

Emil Billbäck appointed new Chair of the Board of Intervacc

Spruce Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates